Term
Compare and contrast traditional drugs, biologics, and complementary and alternate medicine (CAM) therapies. |
|
Definition
- a. TRADITIONAL DRUGS ARE MEDICATIONS WHICH HAVE GONE THROUGH RIGOUROUS TESTING AND APPRROVAL PROCESSES
- b. BIOLOGICS ARE MEDICACATIONS WHICH ARE PRODUCED BY THE BODY
- c. COMPLENENTARY AND ALTERNATIVE MEDICINE THERAPIES ARE THINGS SUCH AS HERBS, VITAMINS, PHYSICAL THERAPY, ACCUPUNCTURE, ETC…
-
|
|
|
Term
Outline the major differences between prescription and over-the-counter (OTC) drugs. |
|
Definition
a. PRESCRIPTION DRUGS ARE DRUGS WHICH MUST BE PRESCRIBED TO SOMEONE BY A DOCTOR AND ARE USUALLY MEDICATIONS WHICH HAVE A HIGH CHANCE OF BEING ABBUSED OR CERTAIN DRUGS WHICH ARE DIFFICULT TO PRODUCE.
b. OVER THE COUNTER (OTC) DRUGS ARE DRUGS WHICH POSE SMALL RISK FOR ABBUSE AND ARE EASILY PRODUCED |
|
|
Term
Discuss the role of the U.S. Food and Drug Administration (FDA) in the drug approval process. |
|
Definition
a. THE FDA CONTROLS THE APPROVAL OF A DRUG FROM THE VERY INCEPTION TO THE FINAL APPROVAL PROCESS. THE PROCESS CAN TAKE MANY YEARS AND THE QUALITY ASSURANCE CONTROLS IN PLACE ARE VERY HIGH |
|
|
Term
Food and Drug Administration
|
|
|
Definition
GOVERNMENT GROUP THAT IS IN CHARGE OF OVERSEEING NEW INTRODUCTION AND TESTING OF DRUGS AND MONITORING QUALITY ASSURANCE
|
|
|
|
Term
Drug Enforcement Administration |
|
Definition
GOVERNMENT GROUP THAT IS RESPONSIBLE FOR MAINTING CONTROL OVER DRUGS AND ENFORCING STATE AND FEDERAL LAWS CONCERING SALE AND POSSESSION OF CERTAIN DRUGS
|
|
|
|
Term
List and discuss the 4 phases of the drug approval process. |
|
Definition
a. PRECLINICAL PHASE: DRUGS ARE TESTED ON ANIMALS
b. CLINICAL INVESTIGATION: HEALTHY HUMAN VOLUNTEERS AND LARGE GROUPS OF PATIENTS WITH DISEASE ARE TESTED
c. NEW DRUG APPLICATION: IF THE DRUG APPEARS TO WORK THEN THE DRUG IS REVIEWED FOR APPROVAL BY THE FDA
d. POST MARKETING SURVEILLANCE: THE DRUG IS MARKETED FOR GENERAL USE WHILE MONITORING THE DRUGS EFFECTS
|
|
|
Term
Therapeutic classification
|
|
|
Definition
BASED ON USEFULLNESS IN TREATING DISEASE
|
|
|
|
Term
Pharmacologic classification
|
|
|
Definition
THE WAY AN AGENT WORKS IN THE BODY
|
|
|
|
Term
|
Definition
A DRUG WHICH REPRESENTS OTHER DRUGS IN THE CLASS
|
|
|
|
Term
|
Definition
THE NAME WHICH A DRUG IS ASSIGNED USING THE STANDARD NOMENCLATURE
|
|
|
|
Term
|
Definition
THE NAME ASSIGNED TO A DRUG BY THE U.S. ADOPTED NAME COUNCIL
|
|
|
|
Term
|
Definition
THE NAME ASSIGNED BY THE COMPANY PRODUCING THE DRUG
|
|
|
|
Term
|
Definition
CONTAINS MORE THAN ONE ACTIVE GENERIC INGREDIENT
|
|
|
|
Term
|
Definition
THE PHYSIOLOGICAL ABILITY OF THE DRUG TO REACH ITS TARGET CELLS
|
|
|
|
Term
|
Definition
OVERWHELMING FEELING THAT DRIVES SOMEONE TO USE A DRUG
|
|
|
|
Term
|
Definition
THE PHYSIOLOGICAL NEED FOR A SUBSTANCE
|
|
|
|
Term
|
Definition
HOW A DRUG IS CLASSIFIED ACCORDING TO ITS POTENTIAL FOR ABUSE
|
|
|
|
Term
Describe what is meant by a drug’s mechanism of action. |
|
Definition
a. THE MECHANISM OF ACTION IS HOW A DRUG PHYSIOLOGICALLY AFFECTS THE BODY |
|
|
Term
Explain the differences between brand-name drugs and their generic equivalents |
|
Definition
a. AFTER 17 YEARS A BRAND NAME DRUG IS AVAILABLE TO OTHER COMPANIES TO PRODUCE. USUALLY THE DRUGS ARE THE SAME BUT SOMETIMES THERE CAN BE DIFFERENCES IN THE FORMULAS |
|
|
Term
|
Definition
HEROIN, MARIJAUNA, AND OTHER ILLEGAL SUBSTANCES AND CERTAIN PAIN KILLERS
|
LIMITED OR NO THERAPEUTIC USE
|
|
|
|
Term
|
Definition
HYROMORPHONE, COCAINE, PENTOBARBITAL, AND OTHER CERTAIN PAIN KILLERS
|
HIGH PROBABLIITY OF ABBUSE
|
|
|
|
Term
|
Definition
COMBINATION PRODUCTS WITH LESS THAN 15 ML’S OF HYDROCODONE PER DOSE, WITH MORE THAN 90 ML’S OF CODEINE PER DOSE, ETC….
|
USED THERAPEUTICALLY WITH PRESCRIPTION; SOME DRUGS NO LONGER USED, MODERATE POTENTIAL FOR ABBUSE
|
|
|
|
Term
|
Definition
DIAZEPAM, LORAZEPAM, MIDAZOLAM, CERTAIN SLEEPING AIDS
|
LOWER POTENTIAL FOR ABUSE
|
|
|
|
Term
|
Definition
COUGH PREPARATIONS CONTAINING NOT MORE THAN 200 ML’S OF CODEINE PER 100 ML’S
|
LOWEST POTENTIAL FOR ABUSE , USED THERAPEUTICLALLY WITHOUT PRESCRIPTION
|
|
|
|
Term
|
Definition
PROCESS INVOLVING THE MOVEMENT OF A SUBSTANCE FORM ITS SITE OF ADMINISTRATION, ACROSS BODY MEMBRANES, TO CIRCULATING FLUIDS
|
|
|
|
Term
|
Definition
INVOLVES THE TRANSPORT OF DRUGS THROUGHOUT THE BODY. LIPID SOLUBILITY IS AN IMPORTANT CHARACTERSISTIC. BONE MARROW, TEETH, EYES AND ADIPOSE TISSUE HAVE A HIGH AFFINITY.
|
|
|
|
Term
|
Definition
THE PROCESS OF CHEMICALLY CONVERTING A DRUG TO A FORM THAT IS USUALLY MORE EASILY REMOVED FORM THE BODY. LIVER IS THE PRIMARY SITE OF DRUG METABOLISM.
|
|
|
|
Term
|
Definition
THE WAY IN WHICH A DRUG IS EXPELLED FROM THE BODY. THE RATE AT WHICH DRUGS ARE EXCRETED FROM THE BODY DETERMINES THE CONCENTRATION OF DRUGS IN THE BODY.
|
|
|
|
Term
Discuss factors affecting drug absorption. |
|
Definition
a. THE FORM THE MEDICATION TAKES
b. THE ROUTE THE MEDICATION TAKES
c. CONCENTRATION OF THE DRUG
d. BODY COMPOSITION |
|
|
Term
Minimum effective Concentration
|
|
|
Definition
THE MINIMUM AMOUNT OF A DRUG TO PRODUCE A THERAPEUTIC EFFECT
|
|
|
|
Term
|
Definition
THE LEVEL OF A DRUG THAT WILL PRODUCE SERIOUS ADVERSE EFFECTS
|
|
|
|
Term
|
Definition
THE RANGE OF A DRUG BETWEEN THE MINIMUM AND THE TOXIC LEVELS. THE LEVEL A DRUG IS DESIGNED TO OPERATE AT
|
|
|
|
Term
|
Definition
THE LENGTH OF TIME FOR A DRUG TO DECREASE IN CONCENTRATION BY ONE HALF
|
|
|
|
Term
|
Definition
A HIGHER DOSE OF A DRUG GIVEN ONCE OR TWICE TO “PRIME” THE BLOODSTREAM.
|
|
|
|
Term
|
Definition
DOSES OF A DRUG GIVEN TO MAINTAIN THAT DRUGS LEVEL IN THE BODY
|
|
|
|
Term
|
Definition
THE AMOUNT OF TIME IT TAKES FOR A DRUG TO PRODUCE AN EFFECT
|
|
|
|
Term
|
Definition
OCCURS WHEN THE LEVEL OF THE DRUG IN THE BODY HAS REACHED ITS HIGHEST CONCENTRATION
|
|
|
|
Term
|
Definition
THE AMOUNT OF TIME IT TAKES FOR A DRUG TO MAINTAIN ITS DESIRED EFFECT UNTIL TERMINATION
|
|
|
|
Term
1Explain the applications of a drug’s onset, peak, and plasma half-life to duration of pharmacotherapy. |
|
Definition
a. WHEN CONSIDERING THE PROPER COURSE OF TREATMENT THE COURSE OF THE DRUG IS TO BE CONSIDERED. FAST ONSET CAN BE USEFUL IN EMERGENCY SITUATIONS WHEN LIFE SAVING DRUGS ARE NEEDED. A LONG HALF LIFE AND PEAK ARE USEFUL WHEN CONSIDERING A CONDITION WHERE LEVELS OF A DRUG ARE NEEDED TO BE MAINTAINED SUCH AS WITH ANTI-PSYCHOTICS |
|
|
Term
Distinguish among an agonist, a partial agonist, and an antagonist. |
|
Definition
a.AN AGONIST IS A DRUG THAT PRODUCES THE SAME OR GREATER TYPE OF RESPONSE AS THE ENDOGENOUS SUBSTANCE
b.A PARTIAL AGONIST IS A DRUG THAT PRODUCES ONLY SLIGHTLY THE SAME EFFECT AS THE ENDOGENOUS SUBSTANCE
c.AN ANTAGONIST IS A DRUG THAT PREVENTS THE ENDOGENOUS SUBSTANCE FROM ACTING ON A RECEPTOR
|
|
|
Term
Explain the relationship between receptors and drug action. |
|
Definition
a. DRUGS ARE DESIGNED TO AFFECT CERTAIN RECEPTORS IN THE BODY WHICH IN TURN EITHER RELEASE OR BLOCK CERTAIN ENDOGENOUS CHEMICALS. DRUGS ARE NORMALLY TAILORED SPECIFICALLY TO AFFECT CERTAIN NEUROTRANSMITTERS. |
|
|
Term
List, in order, the different steps of the nursing process. |
|
Definition
a. ASSESSMENT: FIRST EXAMINING THE PATIENT AND GATHERING BASELINE DATA
b. DIAGNOSING: ANALYZE DATA GATHERED DURING ASSESSMENT AND THEN WORK TO DETERMINE WHAT HEALTH PROBLEMS THERE MAY BE
c. PLANNING: MAKING A CARE PLAN FOR THE PATIENT THAT IS TAILORED TO THEIR EXACT NEEDS
d. IMPLEMENTING: ENSURING THAT THE CARE PLAN DRAWN UP IS CARRIED OUT. IMPLEMENT ANY NURSE INTERVENTIONS THAT ARE DETERMINED TO BE NECESSARY
e. EVALUATING: FOLLOW UP AFTER TREATMENT HAS BEEN GIVEN. RE-ASSESS TO DETERMINE IF PATIENT REQUIRES ANY OTHER INTERVENTIONS AND IF CARE PLAN IS WORKING
|
|
|
Term
|
Definition
ANY SUBSTANCE THAT WHEN EXPOSED TO A FETUS CAN CAUSE PERMANENT DAMAGE AND ABNORMALITIES
|
|
|
|
Term
|
Definition
THE TAKING OF MULTIPLE DRUGS CONCURRENTLY
|
|
|
|
Term
|
Definition
TWO OR MORE VERSAINS OF THE SAME ENZYME
|
|
|
|
Term
|
Definition
THE STUDY OF GENETIC VARIATIONS THAT GIVE RISE TO DIFFERENCES IN DRUG RESPONSE
|
|
|
|
Term
Complementary and Alternative Medicine (CAM)
|
|
|
Definition
INCLUDES CERTAIN HOLISTIC PRACTICES SUCH AS ACCUPUNCTURE, MASSAGE, AND OTHER SUCH CULTURAL PRACTICES
|
|
|
|
Term
1. Identify the 5 categories of teratogenic drug classification. |
|
Definition
a. CATEGORY A: ANIMAL AND HUMAN STUDIES HAVE SHOWN NO RISK TO FETUS
b. CATEGORY B: ANIMAL STUDIES HAVE SHOWN NO HARM BUT NO HUMAN STUDIES EXIST; POSSIBLE RISK
c. CATEGORY C: ANIMAL STUDIES HAVE SHOWN AN ADVERSE EFFECT BUT NO HUMAN STUDIES EXIST; SLIGHT RISK
d. CATEGORY D: HUMAN STUDIES HAVE SHOWN A RISK TO FETUS; MODERATE RISK
e. CATEGORY X: HUMAN AND ANIMAL STUDIES HAVE SHOWN POSITIVE FETAL ABNORMALITIES OR LARGE RISK; LARGE RISK, DO NOT USE |
|
|
Term
Identify the differences that a nurse should be aware of when administering medications to children and older adults? |
|
Definition
a. WHEN ADMINISTERING MEDICATION TO CHILDREN BE GENTLE AND DO NOT CAUSE UNDUE STRESS. BE SURE TO CHECK DOSAGE IS CORRECT FOR A CHILD. TAKE GREAT CARE WHEN ADMINISTERING ANY MEDICATION IV OR IM.
b. WHEN ADMINISTERING MEDICATION TO OLDER ADULTS MAKE SURE TO TREAT THEM WITH THE SAME RESPECT YOU WOULD GIVE A MIDDLE AGED ADULT. BE SURE TO PROVIDE CLEAR AND PRECISE INSTRUCTIONS. ENSURE THE PATIENT IS ALLOWED TO HELP AS MUCH AS POSSIBLE. |
|
|
Term
Explain the roles of complementary and alternative medicine in promoting patient wellness. |
|
Definition
a. OFFERING CAM’S TO PATIENTS CAN OFTEN BE AS BENEFICIAL AS BIOLOGICAL AND TRADITIONAL MEDICINE. MASSAGE IS A VERY EFFECTIVE ACCOMPANIMENT TO STANDARD TREATMENT FOR MOST CONDITIONS. |
|
|
Term
Discuss the role of the nurse in teaching patients about complementary and alternative therapies. |
|
Definition
a. THE NURSE IS TO MAKE ANY AND ALL ACCEPTABLE FORMS OF TREATMENT AVAILABLE TO THE PATIENT. THE NURSE WILL ALSO EDUCATE AND ENCOURAGE THE PATIENT TO SEEK AS MANY POSITIVE AVENUES OF TREATMENT AS POSSIBLE |
|
|
Term
Explain why drugs are important in the context of emergency preparedness. |
|
Definition
a. IN THE EVENT OF A CATASTROPHIC EMERGENCY HAVING READY ACCESS TO CRITICAL DRUGS WILL HELP WITH CONTROLLING THE PROBLEM AS WELL AS HELPING SAVE MORE LIVES IN THE EVEN OF AN EMERGENCY |
|
|
Term
Strategic National Stockpile |
|
Definition
A NATIONAL PROGRAM DESIGNED TO DISTRIBUTE DRUGS TO A COMMUNITY IN THE EVENT OF AN EMERGENCY
|
|
|
|
Term
|
Definition
CAUSED BY THE BACTERIA BACILLUS ANTHRACIS, CAN BE USED AS A BIO-TERROR WEAPON. THREE MAIN TYPES: CUTANEOUS, GASTROINTESTINAL, AND INHALATION ANTHRAX. VERY HARD TO COMBAT.
|
|
|
|
Term
|
Definition
CAN BE USED WITHIN 60 MINUTES OF INGESTION OF A HARMFUL SUBSTANCE. IF PROTECTIVE REFLEXES ARE LOST CANNOT USE BECAUSE OF RISK OF ASPIRATION.
|
|
|
|
Term
|
Definition
ADMINISTERED IF POISON IS CARBON BASED. ABSORBS POISON AND SLOWS ITS RELEASE INTO THE BLOOD STREAM.
|
|
|
|
Term
|
Definition
CAN BE CONSIDERED IF USED AGAINST SLOW/SUSTAINED RELEASE SUBSTANCES OR ENTERIC COATED DRUGS.
|
|
|
|
Term
Identify important divisions of the peripheral nervous system. |
|
Definition
a. MOTOR NEURONS
i. SOMATIC NERVOUS SYSTEM
ii. AUTONOMIC NERVOUS SYSTEM
1. SYMPATHETIC DIVISION
a. ADRENERGIC RECEPTORS
i. ALPHA
ii. BETA
1. PARASYMPATHETIC NERVOUS SYSTEM
a. CHOLINERGIC RECEPTORS
b. SENSORY NEURONS |
|
|
Term
1. Compare and contrast the actions of the sympathetic and parasympathetic divisions of the Autonomic nervous system. |
|
Definition
a. SYMPATHETIC DIVISION IS THE “FIGHT OR FLIGHT” PORTION. IT PREPARES THE BODY FOR ACTION BY DILATING THE PUPILS, RELEASING ADRENELINE, EXPANDING THE BRONCHIOLES, ETC…..
b. PARASYMPATHETIC DIVISION IS THE “REST AND DIGEST” PORTION. IT PREPARES THE BODY TO REST BY INCREASING GASTRIC JUICE OUTPUT, CONSTRICTING THE PUPILS AND BRONCHIOLES, STIMULATING SEX ORGANS, ETC…. |
|
|
Term
|
Definition
CONSISTS OF THE BRAIN AND SPINAL CHORD WHICH CONTROL ALL MOTOR AND SENSORY NEURONS IN THE BODY
|
|
|
|
Term
Peripheral Nervous System
|
|
|
Definition
TRANSMITS SIGNALS BETWEEN THE CNS AND THE PNS
|
|
|
|
Term
|
Definition
CONTROLS INVOLUNTERY RESPONSES BY INFLUENCING ORGANS, GLANDS, AND SMOOTH MUSCLES
|
|
|
|
Term
|
Definition
PREPARES THE BODY FOR “FIGHT OR FLIGHT”
|
|
|
|
Term
|
Definition
PREPARES THE BODY FOR “REST AND DIGEST”
|
|
|
|
Term
|
Definition
RECEPTORS AT THE END OF POST-GANGLIONIC SYMPATHETIC NEURONS WHICH RESPOND TO NOREPINEPHRINE
|
|
|
|
Term
|
Definition
A SUBTYPE OF AN ADRENERGIC RECEPROR
|
|
|
|
Term
|
Definition
A SUBTYPE OF AN ADRENERGIC RECEPTOR
|
|
|
|
Term
|
Definition
RECEPTORS WHICH RESPOND TO ACETYLCHOLINE
|
|
|
|
Term
|
Definition
SPECILIZED CELLS THAT SEND AND RECEIVE INFORMATION FROM OTHER PARTS OF THE BODY
|
|
|
|
Term
|
Definition
STIMULATE THE SYMPATHETIC NERVOUS SYSTEM AND INDUCE “FIGHT OR FLIGHT” RESPONSES; ALSO CALLED ADRENERGIC DRUGS
|
|
|
|
Term
|
Definition
INHIBIT THE SYMPATHETIC NERVOUS SYSTEM AND PRODUCE THE OPPOSITE ACTION OF SYMPATHOMIMETICS
|
|
|
|
Term
|
Definition
STIMULATE THE PARASYMPATHETIC NERVOUS SYSTEM AND INDUCE “REST AND DIGEST” RESPONSES; ALSO CALLED CHOLINERGIC DRUGS
|
|
|
|
Term
|
Definition
INHIBIT THE SYMPATHETIC NERVOUS SYSTEM
|
|
|
|
Term
|
Definition
A SUDDEN DROP IN BLOOD PRESSURE WHEN GOING FROM A SITTING POSITION TO A STANDING POSITION QUICKLY.
|
|
|
|
Term
Phenylephrine (Neo-Synephrine) |
|
Definition
Nasal decongestant, mydriatic drug, antihypotensive
|
Alpha adrenergic agonist,
|
Rebound congestion
|
Severe reactions can occur, should not be used with acute pancreatitis
|
|
|
|
Term
|
Definition
Anti-allergy and cardiac stimulator
|
Stimulates alpha receptors
|
Rapid heart rate
|
|
|
|
Term
|
Definition
Anti-hypertensive
|
Selective adrenergic antagonist that
|
Orthostatic hypotension
|
Stand slowly, take first dose while laying down at bedtime, dizziness
|
|
|
|
Term
|
Definition
Non-obstructive urinary retention agent
|
Stimulates smooth muscle contraction
|
belching
|
Patients with asthma, epilepsy, or parkinsonism should not take.
|
|
|
|
Term
Physostigmine (Antilirium) |
|
Definition
Antidote for atropine induced delerium
|
Inhibits destruction of acetylcholine
|
Bracycardia, asystole, restlessness, seizures, respiratory paralysis
|
Use with caution in patients with asthma, epilepsy, diabetes, cardiovascular disease, or brachycardia
|
|
|
|
Term
|
Definition
Antidote for anticholinesterase poisoning
|
Occupies muscarinic receptors blocking acetylcholine
|
Dry mouth, constipation, urinary retention, increased heart rate
|
Do not give to patients with glaucoma
|
|
|
|
Term
Identify the major types of anxiety disorders. |
|
Definition
generalized anxiety disorder (GAD)
- panic disorder
- phobias
- social anxiety
- obsessive-compulsive disorder (OCD)
- post-traumatic stress disorder (PTSD) |
|
|
Term
Identify the regions of the brain associated with anxiety, sleep, and wakefulness. |
|
Definition
a) LIMBIC SYSTEM- AREA OF THE BRAIN RESPONSIBLE FOR EMOTIONAL EXPRESSION, LEARNING, AND MEMORY
b) RETICULAR FORMATION- NETWORK OF NEURONS WHICH CONNECT THE HYPTHALMUS
c) RETICULAR ACTIVATING SYSTEM- RESPONSIBLE FOR SLEEPING AND WAKEFULNESS |
|
|
Term
Identify the three classes of medications used to treat anxiety and sleep disorders. |
|
Definition
a) ANTIDEPRESSANTS
b) BENZODIAZEPINES
c) BARBITURATES |
|
|
Term
escitalopram oxalate (Lexapro) |
|
Definition
ANTIDEPRESSANT, ANXYIOLYTIC
|
INCREASES SEROTONIN
|
SERONTONIN SYNDROME
|
SHOULD NOT BE USED IN PATIENTS WHO ARE BREASTFEEDING
|
|
|
|
Term
|
Definition
SEDATIVE-HYPNOTIC, ANXYIOLYTIC, ANESTHETIC ADJUNCT
|
BINDS TO GAMMA RECEPTIVE AMINO-BUTYRIC ACID (GABA) RECEPTORS
|
DROWSINESS
|
SHOULD NOT BE USED IN PATIENTS WITH ACCUTE-ANGLE CLAUCOMA, PRIMARY DEPRESSIVE DISORDERS, OR PSYCHOSIS
|
|
|
|
Term
|
Definition
SEDATIVE-HYPNOTIC
|
ACTS ON GABA RECEPTORS TO TREAT INSOMNIA
|
DAYTIME SEDATION AND AMNESIA
|
LACTATING WOMEN SHOULD NOT TAKE
|
|
|
|
Term
|
Definition
CAUSE LOSS OF SENSATION TO THE ENTIRE BODY, USUALLY RESULTING IN LOSS OF CONSCIOUSNESS
|
|
|
|
Term
|
Definition
A. OCCURS WHEN SENSATION IS LOST IN A CERTAIN AREA OF THE BODY |
|
|
Term
|
Definition
A. INJECTION INTO EPIDURAL SPACE OF THE SPINAL CORD; MOST COMMONLY USED DURING LABOR AND DELIVERY |
|
|
Term
|
Definition
A. DIRECT INJECTION INTO TISSUE IMMEDIATE TO THE SURGICAL SITE; DRUG DIFFUSES INTO TISSUE TO BLOCK A SPECIFIC GROUP OF NERVES |
|
|
Term
|
Definition
A. DIRECT INJECTION INTO TISSUE THAT MAY BE DISTANT FROM THE OPERATING SITE; BLOCKS NERVE BUNDLES SERVING A SPECIFIC AREA |
|
|
Term
|
Definition
A. INJECTION INTO THE CEREBRAL SPINAL FLUID; DRUG AFFECTS LARGE, REGIONAL AREA SUCH AS THE LOWER ABDOMEN AND THE LEGS |
|
|
Term
|
Definition
CREAMS, SPRAYS, SUPPOSITORIES, DROPS, LONZENGES; APPLIED TO MUCOUS MEMBRANES |
|
|
Term
|
Definition
THE PRACTICE OF USING MULTIPLE DRUGS TO EFFECT RAPID UNCONSCIOUSNESS, MUSCLE RELAXATION, AND MAITAIN DEEP ANESTHESIA
|
|
|
|
Term
|
Definition
POTENTIALLY FATAL DISORDER THAT CAN BE CAUSED BY CERTAIN GENERAL ANESTHETICS WHICH CAUSES A RAPID INCREASE IN BODY TEMPERATURE
|
|
|
|
Term
|
Definition
ANESTHETIC, ANTI-DYSRYTHMIC
|
BLOCKS PAIN IMPULSES
|
VERY UNCOMMON
|
SHOULD NOT BE USED ON PATIENT WITH SENSITVITY
|
|
|
|
Term
|
Definition
GENERAL ANASTHETIC
|
SUPPRESSES PAIN IN THE CNS
|
ANXIETY AND COMBATIVENESS IN STAGE 2
|
DO NOT USE ON PATIENT WITH HEAD INJURY
|
|
|
|
Term
|
Definition
SEDATIVE-HYPNOTIC, ANTIANXIETY
|
ENHANCES GABA
|
SLOWS RESPIRATORY RATE
|
|
|
|
Term
|
Definition
ANALGESIC
|
BINDS TO OPIOID RECEPTORS AND INHIBITS PAIN PATHWAYS
|
DROWSINESS, NAUSEA, VOMITING
|
|
|
|
Term
|
Definition
GENERAL ANASTHETIC
|
INHIBITS SYMPATHETIC NERVE ACTIVITY
|
PAIN AT INJECTION SITE (IV), LOW BLOOD PRESSURE, SLOW RESPIRATIONS
|
DO NOT USE IN PATIENT WHO HAS KNOW HYPERSENSITIVITY TO DRUG
|
|
|
|
Term
Succinylcholine (Anectine) |
|
Definition
SKELETAL MUSCLE PARALYTIC
|
BLOCKS ACETYLCHOLINE RECEPTORS
|
RESPIRATIONS STOP
|
USE WITH CAUSTION IN PATIENTS WITH BURNS, NEUROMUSCULAR DISEASES, OR CLAUCOMA
|
|
|
|
Term
|
Definition
ANY PREVENTABLE EVENT THAT MY CAUSE OR LEAD TO INNAPROPRIATE MEDICATION USE OR PATIENT HARM |
|
|
Term
Describe organizations that are involved with medication safety |
|
Definition
A. U.S. FOOD AND DRUG ADMINISTRATION (USDA)
B. U.S. PHARMACOPEIA (USP)
C. INSITITURE FOR SAFE MEDICATION PRACTICES (ISMP)
D. THE JOINT COMMISSION |
|
|
Term
Differentiate between the various medication delivery systems |
|
Definition
A. UNIT DOSE SYSTEM- MEDICATIONS PACKAGED INDIVIDUALLY
B. MULTIPLE DOSE SYSTEMS- MORE THAN ONE DOSE IN A CONTAINER
C. AUTOMATED MEDICATION DISPENSING SYSTEMS- COMPUTER STORAGE AND DISPENSING |
|
|
Term
SIX RIGHTS OF MEDICATION ADIMINISTRATION |
|
Definition
a. RIGHT PATIENT
b. RIGHT DRUG
c. RIGHT DOSE
d. RIGHT ROUTE
e. RIGHT TIME
f. RIGHT DOCUMENTATION |
|
|
Term
THREE CHECKS OF MEDICATION ADMINISTRATION |
|
Definition
a. WHEN COLLECTING THE MEDICATIONS
b. PRIOR TO ENTERING THE PATIENTS ROOM
c. AT THE BEDSIDE |
|
|
Term
Describe point-of-care barcode technology and how it improves the accuracy of medication |
|
Definition
A. WITH THIS TYPE OF TECHNOLOGY IT ALLOWS THE NURSE TO CHECK ELECTRONICALLY THAT THEY HAVE THE RIGHT PATIENT BEFORE THEY ADMINISTER THE MEDICATION WHICH HELPS WITH CONFUSION |
|
|
Term
Explain the proper methods of administering oral drugs. |
|
Definition
a. CHECK FOR ALLERGIES
b. CHECK LABEL THREE TIMES
c. OPEN UNIT DOSE AT BEDSIDE
d. POUR LIQUID AT EYE LEVEL
e. RECHECK DRUG CALCULATION OF A DOSE WITH ANOTHER NURSE AS NEDDED
f. ADMINISTER ONLY DRUGS THAT YOU HAVE PREPARED
g. PREPARE MEDICATION FOR ONE PATIENT AT A TIME
h. DO NOT OPEN WRAPPER UNTIL YOU ARE AT THE BEDSIDE |
|
|
Term
Differentiate between the types of medication orders. |
|
Definition
a. WRITTEN ORDER
b. TELEPHONE ORDER
c. VERBAL ORDER
d. COMPUTER ORDER |
|
|
Term
Identify the components of a medication label. |
|
Definition
a. CHEMICAL COMPOSITION
b. WHAT DISEASE OR DISORDER THE DRUG IS USED TO TREAT
c. PRESCRIBING GUIDELINES
d. KNOWN ADVERSE DRUG REACTIONS AND INTERACTIONS
e. WARNINGS AND CAUTIONS ABOUT THE USE OF THE DRUG |
|
|
Term
|
Definition
i. TABLETS
ii. CAPSULES
iii. GRANULES
iv. CHEWABLE
v. COATED
vi. EFFERVESCENT
vii. MODIFIED RELEASE
viii. MULTILAYER
ix. SOLUBLE
x. TROCHE
xi. LOZENGE |
|
|
Term
|
Definition
a. SOLUTIONS
b. SUSPENSIONS
c. EMULSIONS
d. ELIXIRS
e. SYRUPS |
|
|